Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prurigo nodularis: a review.

Michael R Lee1, Stephen Shumack

  • 1Department of Dermatology, Royal North Shore Hospital, Pacific Highway, St Leonards, New South Wales, Australia. mick155@bigpond.net.au

The Australasian Journal of Dermatology
|October 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A tiered secondary poisoning risk assessment approach to prevent unnecessary fish bioaccumulation testing of pharmaceuticals.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Radiotherapy-A Renaissance for Skin Cancer.

The Australasian journal of dermatology·2025
Same author

Practice Guidelines for Teledermatology in Australia: 2025 Update.

The Australasian journal of dermatology·2025
Same author

Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia.

The Australasian journal of dermatology·2025
Same author

Revisiting Visual Criteria of the Ideal Neck in the Young Caucasian Female.

Aesthetic surgery journal·2025
Same author

Evaluation of the EMA log kow trigger for fish BCF testing based on data for several human pharmaceuticals.

Regulatory toxicology and pharmacology : RTP·2024

Prurigo nodularis is a chronic skin condition causing itchy bumps. Research suggests nerve-related inflammation plays a key role, and treatments like glucocorticoids and systemic medications offer relief.

Area of Science:

  • Dermatology
  • Pathophysiology
  • Neuroscience

Background:

  • Prurigo nodularis is a chronic, intensely itchy skin condition with unknown causes.
  • It significantly impacts patients' quality of life and presents treatment challenges.
  • Various systemic conditions are associated with prurigo nodularis, but the link is unclear.

Purpose of the Study:

  • To review the clinical features, associations, pathology, pathogenesis, and treatment of prurigo nodularis.
  • To explore the role of neuropeptides in the condition's development.
  • To consolidate current understanding and treatment options for this difficult-to-treat disease.

Main Methods:

  • Literature review of clinical features, associations, pathology, pathogenesis, and treatment modalities.

Related Experiment Videos

  • Analysis of studies investigating the role of nerve growth factor, calcitonin gene-related peptide, and substance P.
  • Synthesis of data on topical and systemic treatment efficacy.

    • Main Results:

    • Prurigo nodularis is characterized by a papulonodular pruriginous eruption.
    • Increased calcitonin gene-related peptide and substance P nerves suggest a role in neurogenic inflammation and pruritus.
    • Topical glucocorticoids are a primary treatment; topical vitamin D3, capsaicin, and systemic agents like cyclosporin and thalidomide also show efficacy.

    Conclusions:

    • Prurigo nodularis involves complex pathogenesis potentially mediated by neuropeptides.
    • Effective management includes topical corticosteroids, with other topical and systemic options available.
    • Further research into pathogenesis may reveal novel therapeutic targets for this challenging condition.